Gillies G E, Linton E A, Lowry P J
Nature. 1982 Sep 23;299(5881):355-7. doi: 10.1038/299355a0.
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
最初,人们认为负责释放促肾上腺皮质激素(CRF)的下丘脑因子是一种简单的肽。最近的研究得出结论,CRF是一种多因素复合体。1979年我们提出,血管加压素作为CRF候选物备受争议,它是该复合体的主要成分,与其他成分相互作用以增强CRF活性。最近对一种41个氨基酸残基的绵羊下丘脑肽进行了表征,该肽能够以剂量相关的方式释放促肾上腺皮质激素(ACTH),这使我们能够将其CRF生物活性与血管加压素以及下丘脑的简单提取物进行比较,并研究它在ACTH释放过程中与血管加压素及其他下丘脑因子可能存在的相互作用。我们在此报告,这种新的CRF在释放ACTH方面比血管加压素更有效。当与血管加压素同时给予时,观察到CRF活性有四倍的增强,且具有陡峭的剂量反应特征。它还增强了不含血管加压素的下丘脑提取物的活性,这表明新的CRF并不能解释CRF复合体中所有非血管加压素部分的活性。